Ishares Msci Brazil ETF vs Personalis Inc. Common Stock — how do they compare? Ishares Msci Brazil ETF trades at $42.19 (market cap $13.14B), while Personalis Inc. Common Stock trades at $16.07 (market cap $1.69B). The key difference: Ishares Msci Brazil ETF is far larger — about 7.8× Personalis Inc. Common Stock's market cap, and Ishares Msci Brazil ETF is more actively traded (52,443,793 versus 3,817,236). Which is the better fit depends on your goals — on Pluang, investors hold Ishares Msci Brazil ETF for 50 Days and Personalis Inc. Common Stock for 0 Days on average.
| EWZ | PSNL | |
|---|---|---|
Market Cap | $13.14B | $1.69B |
Volume | 52,443,793 | 3,817,236 |
Sector | Broad Market / Factor | Health |
52-Week High | $43.54 | $18.38 |
52-Week Low | $29.24 | $5.04 |
Typical Hold Time | 50 Days | 0 Days |
Enterprise Value | — | $1.52B |
Signals from Pluang's Aura AI — not financial advice
EWZ, the iShares MSCI Brazil ETF, trades at $42.87, down 1.54% today, with a bullish technical signal driven by moving averages but showing overbought RSI levels. The ETF is attracting significant attention due to Brazil's upcoming October election, with institutional investors accumulating positions through call options. Recent news highlights EWZ as a diversification tool against U.S. tech concentration and potential beneficiary of Brazilian economic policies.
The outlook for EWZ hinges on Brazil's political election outcome and commodity trends, offering asymmetric upside but facing currency and political volatility risks. Wall Street positioning suggests optimism, though investors must weigh the ETF's higher expense ratio against alternatives like FLBR for Brazilian exposure.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
EWZ is a country-specific ETF that tracks the Brazilian equity market. It provides exposure to large and mid-sized companies in Brazil, with a heavy focus on financials and materials, including major names like Nu Holdings, Vale, and Itaú Unibanco.
Read more on EWZ →Personalis Inc. is a cancer genomics company that provides tumor- and blood-based DNA and RNA sequencing tests, including its NeXT Personal liquid biopsy test for cancer monitoring.
Read more on PSNL →